Table 1.
Demographic and clinical characteristics of the interviewees, and of the rest of the cohort
| Interviewees (N = 20) | Refused/no reaction (N = 57) |
Total cohort (N = 108) | ||||
|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |
| Baseline characteristicsa | ||||||
| Age (M ± SD) | 25 ± 9 | 25 ± 7 | 25 ± 7 | |||
| Male | 12 | 60 | 24 | 42 | 62 | 57 |
| Unemployed/passive | 5 | 25 | 10 | 17 | 24 | 22 |
| Civil status, single | 13 | 65 | 43 | 75 | 82 | 76 |
| Living alone | 5 | 25 | 20 | 35 | 38 | 35 |
| Treatment group (inclusion years)b | ||||||
| API (1992–1993) | 10 | 50 | 15 | 26 | 37 | 34 |
| ODAP (1994–1997) | 5 | 25 | 27 | 47 | 47 | 43 |
| ODAP-II (2003–2005) | 5 | 25 | 15 | 26 | 24 | 23 |
| Diagnosis | ||||||
| Acute/transient | 9 | 45 | 24 | 42 | 49 | 45 |
| Schizophreniform | 4 | 20 | 11 | 19 | 22 | 20 |
| Schizophrenia | 7 | 35 | 22 | 39 | 38 | 35 |
| Antipsychotics in first year | 7 | 35 | 11 | 19 | 22 | 20 |
| Hospital admission in first year | 12 | 60 | 24 | 42 | 43 | 40 |
| Treatment during follow-upc | ||||||
| Hospital days (M ± SD) | 100 ± 200 | 62 ± 123 | 63 ± 131 | |||
| Hospital admissions (M ± SD) | 4 ± 5 | 3 ± 4 | 3 ± 5 | |||
| Antipsychotics | 13 | 65 | 31 | 54 | 59 | 55 |
| Characteristics at the time of the interviewc,d | ||||||
| Age (M ± SD) | 45 ± 11 | 44 ± 9 | 45 ± 9 | |||
| Disability allowance | 8 | 40 | 18 | 32 | 32 | 33 |
| Antipsychotics | 7 | 35 | 18 | 32 | 32 | 33 |
| Treatment contact | 7 | 35 | 16 | 28 | 26 | 27 |
M mean, SD standard deviation, API Acute Psychosis Integrated study, ODAP Open Dialogue in Acute Psychosis study
aMore detailed information on baseline characteristics, treatment groups, and diagnostic procedures are described elsewhere (Bergström, 2020)
bInclusion period of three Open Dialogue research projects
cData were gathered as part of long-term register-based follow-up (Bergström et al., 2018)
dOnly people still alive at the end of the follow-up